Galaxy Diagnostics, Inc.
PrivateLast Round
Strategic
May 1, 2026
Total Funding Raised
$2.33M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Galaxy Diagnostics, Inc. operates in Healthcare & Life Sciences and is based in North Carolina. Its latest recorded funding round was a Debt round in July 2024.
Galaxy Diagnostics, Inc. is a biotechnology company that develops and provides advanced diagnostic tests for detecting vector-borne pathogens, such as those causing Bartonellosis and Lyme disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Galaxy Diagnostics, Inc. Comparables
Compare Galaxy Diagnostics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| IGeneX | 85% | |
| T Lab Inc. | 83% | |
| BlueArc Biosciences | 82% |
For institutional investors. Book with your work email.
Galaxy Diagnostics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | May 1, 2026 | ||||
| Seed | Apr 9, 2025 | ||||
| Debt | Jul 10, 2024 | ||||
| VC Round | Jan 14, 2015 | ||||
| Seed | Jul 29, 2014 | ||||
VC Round | Sep 4, 2013 |
For institutional investors. Book with your work email.
Galaxy Diagnostics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Triangle Tweener Fund | Debt, Strategic |
| Ariel Savannah Angel Partners | Strategic |
| North Carolina Biotechnology Center | Debt |
| Center for Entrepreneurial Development | Strategic |
| Boston Harbor Angels | Debt, Strategic |
| Wisconsin Investment Partners | Strategic |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 18, 2026
Monthly visitors increased 78% MoM, reaching 7.8K.
- May 1, 2026
Raised $3M in a Seed Round.
For institutional investors. Book with your work email.
Galaxy Diagnostics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Galaxy Diagnostics, Inc.'s valuation, stock price, and market status.
Is Galaxy Diagnostics, Inc. a public or private company?
Galaxy Diagnostics, Inc. is a private company.
What is the current stock price of Galaxy Diagnostics, Inc.?
Galaxy Diagnostics, Inc. is a private company, so its shares have no public market price. Caplight tracks Galaxy Diagnostics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Galaxy Diagnostics, Inc. worth (valuation)?
Valuation information for Galaxy Diagnostics, Inc. is not publicly available.
Can I buy Galaxy Diagnostics, Inc. stock?
Galaxy Diagnostics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Galaxy Diagnostics, Inc.'s last funding round?
Galaxy Diagnostics, Inc.'s most recent funding round was Strategic on May 1, 2026.
Who are the main investors in Galaxy Diagnostics, Inc.?
Key investors in Galaxy Diagnostics, Inc. include Bay Area Lyme Foundation.
Will Galaxy Diagnostics, Inc. IPO soon?
No public IPO plans have been announced for Galaxy Diagnostics, Inc..
How can I track Galaxy Diagnostics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Galaxy Diagnostics, Inc.'s shares on secondary markets.